Back to Search
FRED LUBLIN, M.D.
M.D.
Neurology Physician
NPI: 1568433803IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
116580(NY)
CMS Specialties
PrimaryNEUROLOGY
Education
JEFFERSON MEDICAL COLLEGE OF THOMAS JEFFERSON UNIVERSITY
Class of 1972
Research & Publications (20)
The incomplete nature of multiple sclerosis relapse resolution.
PMID 17337274·J Neurol Sci·2007
6-review
Multiple sclerosis trial designs for the 21st century: building on recent lessons.
PMID 16254702·J Neurol·2005
6-review
Effect of relapses on development of residual deficit in multiple sclerosis.
PMID 14663037·Neurology·2003
8-other
When marketing and science intersect: do patients with MS benefit?
PMID 12451185·Neurology·2002
8-other
Therapeutic approaches to secondary progressive multiple sclerosis.
PMID 11936495·Mult Scler·2002
6-review
Placebo-controlled clinical trials in multiple sclerosis: ethical considerations. National Multiple Sclerosis Society (USA) Task Force on Placebo-Controlled Clinical Trials in MS.
PMID 11357961·Ann Neurol·2001
8-other
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL.
PMID 19308305·J Neurol·2009
2-rct
Clinically isolated syndrome and multiple sclerosis: rethinking the arsenal.
PMID 19364454·Curr Treat Options Neurol·2009
8-other
Proof of concept studies for tissue-protective agents in multiple sclerosis.
PMID 19389749·Mult Scler·2009
6-review
Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a.
PMID 19506220·Neurology·2009
3-trial
GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled study.
PMID 19255407·Neurology·2009
3-trial
Assessing disability progression with the Multiple Sclerosis Functional Composite.
PMID 19667023·Mult Scler·2009
8-other
Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study.
PMID 19201654·Lancet Neurol·2009
3-trial
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment.
PMID 18362273·Neurology·2008
6-review
Multiple sclerosis: new treatment trials and emerging therapeutic targets.
PMID 18451708·Curr Opin Neurol·2008
6-review
Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
PMID 18645164·Neurology·2008
4-observational
Differential diagnosis of suspected multiple sclerosis: a consensus approach.
PMID 18805839·Mult Scler·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5 E 98TH ST
NEW YORK, NY 10029 - Phone
- (212) 241-6854
Quick Facts
- NPI
- 1568433803
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 54
- Publications
- 20
Are you this provider?
Claim Your Profile